# A Drug-Drug Interaction Study of Losartan and PA21

> **NCT01324752** · PHASE1 · COMPLETED · sponsor: **Vifor Pharma** · enrollment: 36 (actual)

## Conditions studied

- Drug Interaction Potentiation

## Interventions

- **DRUG:** PA21 and Losartan with Food
- **DRUG:** No PA21; Losartan with food
- **DRUG:** PA21 with food and Losartan 2 hours later

## Key facts

- **NCT ID:** NCT01324752
- **Lead sponsor:** Vifor Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01324752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01324752, "A Drug-Drug Interaction Study of Losartan and PA21". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01324752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*